Clinical Trial Update: Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the combination of avelumab, cetuximab, and palbociclib in recurrent or metastatic head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Cetuximab (cetuximab)
• Palbociclib (palbociclib)

Snippet

Sponsor: Kathryn Gold | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING